COMBINED USE OF ANTI-TROP-2 ANTIBODY-DRUG CONJUGATE AND OTHER THERAPEUTIC AGENTS

A combination of an anti-TROP-2 antibody-drug conjugate and anti-PD-L1 antibody or other chemotherapeutic drugs such as carboplatin or cisplatin, and an application of the combination in the preparation of drugs for preventing and/or treating tumor diseases, wherein the anti-TROP-2 antibody may be S...

Full description

Saved in:
Bibliographic Details
Main Authors GUO, Qi, PAN, Yang, LIU, Gesha, YIN, Wenguo, WEI, Yujun, WANG, Suxia, GE, Junyou, DIAO, Yina, LU, Lian, JIN, Xiaoping
Format Patent
LanguageEnglish
Published 25.07.2024
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:A combination of an anti-TROP-2 antibody-drug conjugate and anti-PD-L1 antibody or other chemotherapeutic drugs such as carboplatin or cisplatin, and an application of the combination in the preparation of drugs for preventing and/or treating tumor diseases, wherein the anti-TROP-2 antibody may be Sacituzumab.
Bibliography:Application Number: AU20230207213